Acurx Pharmaceuticals, Inc. ACXP 深 沪
交易中 08-20 11:20:25 美东时间
1.445
+0.005
+0.35%
华盛通- 最 高1.45
- 今 开1.41
- 成交量 7.17万股
- 最 低 1.39
- 昨 收 1.44
- 总市值 761.50万
- 52周最高 8.34
- 市盈率 静 --
- 换手率 1.36%
- 52周最低 1.31
- 委 比 75.44%
- 总股本 526.99万
- 历史最高 176.40
- 量 比 0.60
- 振 幅 4.17%
- 历史最低 1.31
- 每 手 1
- 风险率 1.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.37) by 43.24 percent. This is a 71.96 percent increase over losses of $(1.89) per share from the same period last year.
08-14 19:02
Acurx Pharmaceuticals Announces Intent For Further Discussion With FDA Regarding Ibezapolstat's Phase 3 Clinical Program, Scope Of Its Planned NDA
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced the successful outcome of a Type C Meeting conducted with FDA on July 13, 2026 to discuss ibezapolstat's Phase 3 cli...
08-03 20:08
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
STATEN ISLAND, N.Y., April 29, 2026 /PRNewswire/ -- Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a fully-integrated biopharmaceutical company developing a new class of antibi...
04-29 20:00
Acurx Pharmaceuticals Announces $7.1M Registered Direct Offering Of 825,085 Shares At $3.03/Share
$2.5 million upfront with up to an additional $4.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
04-16 20:10
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
Acurx Pharma Granted Korean Patent For DNA Polymerase IIIC Inhibitors Including Compositions‑Of‑Matter, Methods Of Use, And Pharmaceutical Compositions
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial infections, today
03-30 19:17
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
STATEN ISLAND, N.Y., March 30, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of sm...
03-30 19:01
美股夜盘 | Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%，网络齿轮通信涨16.41%
Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%；网络齿轮通信涨16.41%；BioCryst制药涨14.18%
03-24 15:02
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Serina Therapeutics (AMEX:SER) shares moved upwards by 94.5% to $2.49 d...
03-20 01:05
Earnings Scheduled For March 13, 2026
Companies Reporting Before The Bell • Douglas Elliman (NYSE:DOUG) is likely to ...
03-13 19:11
